Familial primary biliary cirrhosis reassessed: a geographically-based population study
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Background/aims Development of primary biliary cirrhosis in the close relatives of patients with the disease has been reported in several series, suggesting a genetic component to disease susceptibility. In this study we set out to calculate, as accurately as possible, the prevalence of familial primary biliary cirrhosis in a geographically-based population. Using local population prevalence data, we have also calculated the first-degree relative, sibling and offspring relative risks of overt primary biliary cirrhosis development. Methods All patients with definite or probable primary biliary cirrhosis in the city of Newcastle-upon-Tyne, England, were identified by an exhaustive case-finding search and were prospectively interviewed by a single investigator. Full details of family pedigree and familial primary biliary cirrhosis history were obtained. Results One hundred and seventy-three patients were identified, with 160 participating in the study. Thirteen reported a family history of primary biliary cirrhosis. In three cases, both relative pairs were within the study group. The prevalence of a positive family history of primary biliary cirrhosis was therefore 10/157 (6.4% [95% Confidence Interval 2.6-10.2%]), 8/10 cases occurring in first-degree relatives. The patients had a total of 1118 first-degree relatives (live or dead) and 468 siblings. The first-degree relative prevalence of primary biliary cirrhosis was 0.72% [0.2-1.2%] (siblings 0.41% [-0.2-1.0%]). The offspring…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Familial PBC is clearly recognised, with familial rates similar to those seen in other autoimmune conditions.”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [37]
In the citing paper
“The relative risk for familial disease is greatest, at 35, for the daughters of mothers with PBC, reflecting in part the disease demographics.”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [37]
In the citing paper
“Patients with PBC typically have an increased incidence, in both themselves and their families, of other autoimmune diseases (over half of patients with PBC have another autoimmune condition), reflecting shared genetic predisposition (most notably but not exclusively celiac disease, scleroderma, thyroid disease and Sjögren’s).37–43”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [37]
In the citing paper
“The reported sibling relative risk for PBC is 10.37”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [37]
In the citing paper
“In the case of PBC, the sibling relative risk is 10 (siblings of a patient with PBC have a 10.5-fold higher risk of developing the disease than age- and sex-matched community controls), while the relative risk rises to 35 for the daughters of patients with PBC.37”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [37]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Genetic Analysis of Autoimmune Disease
Vyse, T. J., & Todd, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81110-1 · Cited by 717
Symposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Assessing the role of HLA-linked and unlinked determinants of disease.
RISCH, N. J. (1987) · PubMed · Cited by 539
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
Satsangl, J., Farrant, J. M., Jewell, D. P., Bell, J. I., Welsh, K. I., Bunce, M., & Julier, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90734-5 · Cited by 368
Genetic analysis of type 1 diabetes using whole genome approaches.
Todd, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8560 · Cited by 253
Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England
Metcalf, J., Bhopal, R., Gray, J., Howel, D., & James, O. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.4.830 · Cited by 176
Self-citationHLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis
Manns, M. P., Bremm, A., Schneider, P. M., Notghi, A., Gerken, G., Prager-Eberle, M., Stradmann‐Bellinghausen, B., Büschenfelde, K. M. Z., & Rittner, C. K. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90090-8 · Cited by 134
Familial primary biliary cirrhosis
Bach, N., & Schaffner, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80137-0 · Cited by 128
Research works printed but not linked: 2
- James, 1998, Demography of primary biliary cirrhosis in North-East England, Gastroenterology
- Watt, 1997, TNF and HLA DR8 polymorphisms in PBC: genetic control of disease progression, Hepatology, 26, 440A
Cited by
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Metadata
- Authors
- Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Jones, David EJ
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 30
- Issue
- 3
- Pages
- 402-407
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2044480628
- Cited by
- 213
- References
- 25
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 14 · 2017: 7 · 2016: 1 · 2015: 14 · 2014: 10 · 2013: 8 · 2012: 13
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- primary biliary cirrhosis, family history (medicine), first-degree relatives, familial prevalence, genetic susceptibility, autoimmune liver disease, Newcastle upon Tyne
- MeSH terms
- Adult, Aged, Female, United Kingdom, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Pedigree, Risk Factors, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Familial primary biliary cirrhosis reassessed: a geographically-based population study. https://app.cochat.ai/papers/10.1016/s0168-8278(99)80097-x
- The paper
- Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W. (1999). Familial primary biliary cirrhosis reassessed: a geographically-based population study. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(99)80097-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.